# Integra LifeSciences to acquire Codman Neurosurgery from Johnson & Johnson for $1.045 billion

Integra LifeSciences has made a binding offer to acquire the Codman Neurosurgery business from Johnson & Johnson for $1.045 billion in cash. The acquisition includes a portfolio of devices for hydrocephalus, neuro-critical care, and operative neurosurgery.

- Type: Acquisition
- Announced: 2017-02-15
- Where: United States
- Value: $1.04B
- Status: announced
- Products: neurosurgical devices, hydrocephalus devices, neuro-critical care devices, electrosurgery devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Johnson & Johnson](https://endata.com/companies/9845.md) (target)
- [Integra LifeSciences](https://endata.com/companies/21365.md) (acquirer)
- [Codman Neurosurgery](https://endata.com/companies/22719.md) (target)

## Sources

- [investor.integralife.com](https://investor.integralife.com/news-releases/news-release-details/integra-lifesciences-plans-acquire-codman-neurosurgery-business), 2017-02-15: "This proposed transformational acquisition of Codman Neurosurgery creates compelling value for our shareholders, employees and patients."
- [neuronewsinternational.com](http://neuronewsinternational.com/integra-lifesciences-to-acquire-codman-neurosurgery-business-from-johnson-johnson/), 2017-03-08: "Integra LifeSciences Holdings Corporation has made a binding offer to acquire the Johnson & Johnson Codman Neurosurgery business for a price of US$1.045 billion in cash."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.